Inspecs Group (LSE:SPEC) Research & Development: £0.0 Mil (TTM As of Dec. 2025)


LSE:SPEC Inspecs Group PLC LSE:SPEC
52 GF Score
Price £0.97
GF Value £0.58
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Inspecs Group Research & Development?

Inspecs Group LSE:SPEC 52 Research & Development is £0.0 Mil as of Dec. 2025. GuruFocus rates LSE:SPEC with a GF Score™ of 52/100 and a GF Value™ of £0.58 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Inspecs Group's Research & Development for the six months ended in Dec. 2025 was £0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was £0.0 Mil.

Inspecs Group  (LSE:SPEC) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Inspecs Group Research & Development Related Terms

Inspecs Group Research & Development Historical Data

* Premium members only.

The historical data trend for Inspecs Group's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Inspecs Group Research & Development Chart

Inspecs Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Inspecs Group Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
LSE:SPEC
52GF Score
Inspecs Group PLC LSE:SPEC
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Inspecs Group Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of £0.0 Mil mean?
Inspecs Group (LSE:SPEC) has a Research & Development of £0.0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Inspecs Group and its competitors.
Is Inspecs Group's Research & Development too high?
Inspecs Group's current Research & Development is £0.0 Mil. Overall, Inspecs Group has a GF Score™ of 52/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Inspecs Group's Research & Development compare to ISRG and BDX?
Inspecs Group's Research & Development of £0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Inspecs Group and its competitors. Inspecs Group's current Research & Development is £0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inspecs Group stock overvalued right now?
Based on GuruFocus' analysis, Inspecs Group (LSE:SPEC) is currently considered Significantly Overvalued. The stock's GF Value™ is £0.58, compared to a current price of £0.97 — trading 67.2% above its estimated fair value. The current Research & Development is £0.0 Mil. Inspecs Group's overall GF Score™ is 52/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Inspecs Group (LSE:SPEC), the current Research & Development is £0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Inspecs Group (LSE:SPEC) Overvalued in 2026?

Based on GuruFocus' analysis, Inspecs Group stock appears to be overvalued. The current stock price of £0.97 is trading 67.2% above its estimated GF Value™ of £0.58. GuruFocus considers Inspecs Group to be Significantly Overvalued.

Key valuation signals for LSE:SPEC:

  • Research & Development: £0.0 Mil
  • GF Value™: £0.58 vs. price of £0.97 (67.2% above fair value)
  • GF Score™: 52/100 with 6 warning signs

No single metric tells the full story. See the LSE:SPEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Inspecs Group Business Description

Address Upper Bristol Road, 7-10 Kelso Place, Bath, Somerset, GBR, BA1 3AU
Inspecs Group PLC is a designer and manufacturer of eyewear frames and accessories. The customers of the company include optical and Non-optical retailers, distributors, and independent opticians. The company operations are spread across the United Kingdom, Europe (excluding the UK), South America, North America, Asia, Africa, and Australia. Its eyewear brands include Superdry, Titanflex, O'Neill, Brendel, Humphreys, Marc O'Polo, and among others. The reporting segments of the company are Frames and Optics product distribution which derives maximum revenue, and Manufacturing includes OEM and manufacturing distribution segment.
52GF Score

Get the complete analysis for LSE:SPEC

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£0.97
Price
£0.58
GF Value